Passage Bio, Inc. (PASG) - Quarterly Income Statement

Home
PASG
Financials

0.46 (USD) • At close March 7, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4
Revenue Numbers are in millions	0	0	0	0	5.912	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.8	0.806	0.807	1	0.978	0.978	0.946	0.929	0.921	0.883	0.669	0.46	0.203	0.211	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	-0.8	-0.806	5.105	-1	-0.978	-0.978	-0.946	-0.929	-0.921	-0.883	-0.669	-0.46	-0.203	-0.211	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	9.558	8.656	10.43	11.535	12.161	15.098	17.324	16.836	17.657	15.362	26.821	26.213	32.968	26.623	33.112	24.97	27.932	20.837	19.902	13.117	9.972	10.434	6.299	3.033	5.941
General & Administrative Expenses Numbers are in millions	4.712	7.251	6.51	6.515	6.285	8.184	8.064	19.047	10.587	10.664	12.991	15.099	17.192	14.978	15.422	12.464	10.124	7.793	7.402	4.795	3.62	1.209	0.968	1.154	0.481
Selling & Marketing Expenses Numbers are in millions	0	0	0	-0.806	-0.807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.712	7.251	6.51	5.709	5.478	8.184	8.064	19.047	10.587	10.664	12.991	15.099	17.192	14.978	15.422	12.464	10.124	7.793	7.402	4.795	3.62	1.209	0.968	1.154	0.481
Other Expenses Numbers are in millions	0	4.795	0.438	1.339	1.688	1.562	1.532	1.545	0	0.825	0.27	0.001	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	14.27	20.702	17.378	17.244	17.639	23.282	25.388	35.883	28.244	26.026	39.812	41.312	50.16	41.601	48.534	37.434	38.056	28.63	27.304	17.912	13.592	11.643	7.267	4.187	5.819
Operating Income Numbers are in millions	-14.27	-20.702	-17.378	-18.05	-18.446	-28.672	-25.388	-35.883	-28.244	-27.526	-39.812	-42.812	-51.16	-47.101	-48.534	-38.934	-39.056	-28.63	-27.304	-17.912	-13.592	-11.643	-7.767	-4.187	-6.422
Operating Income Ratio Numbers are in millions	0	0	0	0	-3.12	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	1.545	1.362	1.387	1.339	1.688	1.562	1.532	1.545	1.173	0.825	0.27	0.001	0.006	0.186	0.099	0.052	0.112	0.099	0.132	0.327	0.441	0.255	-5.659	-3.482	0.603
Income Before Tax Numbers are in millions	-12.725	-19.34	-15.991	-16.711	-16.758	-27.11	-23.856	-34.338	-27.071	-26.701	-39.542	-42.811	-51.154	-46.915	-48.435	-38.882	-38.944	-28.531	-27.172	-17.585	-13.151	-11.388	-13.426	-7.669	-5.819
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-2.835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	-0	3.481	-0.958	-0.978	-1.545	-1.173	-0.825	-0.27	-0.001	-0.006	-0.186	-0.099	2.896	-0.112	-0.099	-0.132	-0.654	-0.441	-0.255	5.659	6.964	0.603
Net Income Numbers are in millions	-12.725	-19.34	-15.991	-16.711	-16.758	-27.11	-23.856	-32.793	-25.898	-25.876	-39.272	-42.81	-51.154	-46.915	-48.435	-38.882	-38.944	-28.531	-27.172	-17.585	-13.151	-11.388	-13.426	-7.669	-5.819
Net Income Ratio Numbers are in millions	0	0	0	0	-2.835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.21	-0.31	-0.26	-0.3	-0.31	-0.49	-0.44	-0.6	-0.47	-0.48	-0.72	-0.79	-0.95	-0.87	-0.9	-0.76	-0.85	-0.63	-0.6	-1	-0.55	-0.48	-0.56	-0.32	-1.47
EPS Diluted Numbers are in millions	-0.21	-0.31	-0.26	-0.3	-0.31	-0.49	-0.44	-0.6	-0.47	-0.48	-0.72	-0.79	-0.95	-0.87	-0.9	-0.76	-0.85	-0.63	-0.6	-1	-0.55	-0.48	-0.56	-0.32	-1.47
EBITDA Numbers are in millions	-13.551	-15.148	-16.143	-17.244	-17.639	-22.324	-24.41	-35.883	-26.125	-25.097	-38.891	-40.429	-49.491	-41.141	-48.331	-37.223	-37.778	-28.355	-27.106	-17.863	-13.547	-11.602	-7.231	-4.175	0.603
EBITDA Ratio Numbers are in millions	0	0	0	0	-2.984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Passage Bio, Inc.

NASDAQ:PASG Add to watchlist

NASDAQ:PASG